SCHEMBL4190071

SCHEMBL4190071

C=C(C)C(=O)OC(COc1ccc(Cl)cc1OCC(COc1ccccc1-c1ccccc1)OC(=O)C(=C)C)COc1ccccc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.46
L3MBTL1 Q9Y468 5/20 0.41
HTT P42858 3/20 0.41
PLA2G1B P04054 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
PTGER1 P34995 3/20 0.40
TDP1 Q9NUW8 3/20 0.39
LMNA P02545 3/20 0.39
MAPK1 P28482 3/20 0.39
CYP2C9 P11712 1/20 0.39
SLC6A9 P48067 1/20 0.39
ADRB2 P07550 2/20 0.38
ADRB1 P08588 1/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR1A P08908 1/20 0.38
HTR7 P34969 1/20 0.38
USP2 O75604 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4202053 0.90 L3MBTL1 (0.46) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL4193703 0.88 L3MBTL1 (0.46) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL21842315 0.84 L3MBTL1 (0.43) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL4197860 0.84 L3MBTL1 (0.43) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL4197809 0.84 L3MBTL1 (0.48) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL4198441 0.83 L3MBTL1 (0.40) L3MBTL1HTTPLA2G1BATG4BPTGER1
SCHEMBL4186157 0.83 L3MBTL1 (0.42) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL4188675 0.82 MAPT (0.42) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL4197498 0.82 MAPT (0.42) L3MBTL1HTTTDP1LMNAMAPK1
SCHEMBL4190840 0.82 L3MBTL1 (0.46) PTGDR2L3MBTL1HTTTDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 PTGDR2 468/4885L3MBTL1 2124/4885HTT 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.